Cohere Health vs SamaCare
Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Cohere Health | SamaCare | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · scoped by UM volume and model | Free to providers (funded by payers/pharma) · Pharma funds premium services and data |
| Speed to go live | deep payer UM integration, multi-month program | Web portal, no IT project required |
| Automation model | Software platform · AI-assisted utilization management decisioning | Software platform · Unified PA portal, AI touchless tier |
| Built for | Payers | Small practices, Mid-size groups |
| Security posture | HITRUST, HIPAA | SOC 2 Type I, HIPAA |
| Company maturity | 7 yrs (est. 2019) | 8 yrs (est. 2018) |
| Financial backing | $200M · Series C | $33M+ · Series B |
| Named customers | 3 named | None public |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 3 listed | 4 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Cohere Health if you are a health plan replacing legacy utilization management with AI-driven prior auth at Humana-proven scale.
- Pick SamaCare if you are a specialty practice buried in medical-benefit prior auths and want one free web portal replacing faxes and payer portals today.
Cohere Health
Intelligent prior auth platform for payers
- Founded
- 2019
- HQ
- Boston, MA
- Stage
- Series C
- Raised
- $200M
What it does
- Automates prior auth intake, review, and approval for health plans
- Auto-approves up to 90 percent of eligible auth requests
- Applies evidence-based clinical policies and physician-facing nudges
- Provider performance analytics to steer utilization management
- Payment integrity claims validation via Cohere Validate
- Delegated UM services across MSK, cardiology, imaging, sleep
Where it's strong
- Proven at national scale: over 12 million prior auth requests a year across roughly 600,000 providers, including a nationwide Humana deployment.
- High auto-approval rates (up to 90 percent) materially cut turnaround times and provider abrasion, which matters as CMS-0057 deadlines arrive.
- Well capitalized at $200M raised and expanding beyond prior auth into payment integrity, reducing single-product risk.
What buyers should weigh
- It sells to health plans, not providers; a provider organization only encounters Cohere through a payer that has adopted it.
- Much of its track record is concentrated in the Humana relationship, so plans of smaller size should ask for comparable references.
- Delegated UM and clinical policy alignment make implementations substantial projects with real compliance and integration work, not a light SaaS install.
Named customers
Humana · Geisinger Health Plan · Medical Mutual of Ohio
Integrations
SamaCare
Prior authorization platform for buy-and-bill specialty drugs
- Founded
- 2018
- HQ
- San Francisco, CA
- Stage
- Series B
- Raised
- $33M+
What it does
- One portal for all medical benefit PA submissions
- AI-assisted form completion and payer requirements
- Status tracking, renewals, and expiration alerts
- Benefit verification and enrollment workflows
- Approval analytics across a 20K-provider network
Where it's strong
- Purpose-built for buy-and-bill drugs, a workflow retail-focused PA tools handle poorly.
- Free for practices because pharma funds it, which removes the budget fight.
- Network data from roughly 20,000 providers improves payer form accuracy and approval odds.
What buyers should weigh
- The pharma-funded model means manufacturers see aggregate data; understand the data terms before signing.
- Scope is medication PA for specialty drugs, not procedures, imaging, or surgical auths.
- Smaller company (Series B) than incumbent networks, so vendor risk is higher than with McKesson or Optum.
Integrations
Compare against the rest of Prior Authorization
Deciding between these two?
First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.